D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.14% |
| 2 | Financials | 9.37% |
| 3 | Healthcare | 7.49% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
Columbus McKinnon
CMCO
$480M
| $308K | ﹤0.01% |
11,790
-4,306
| -27% | -$131K |
|
4127
On Holding
ONON
$12.7B
| $308K | ﹤0.01% |
+19,190
| New | +$383K |
|
|
ATCO
4128
DELISTED
Atlas Corp.
ATCO
| $308K | ﹤0.01% |
22,186
+5,975
| +37% | +$77.8K |
|
|
LHCG
4129
DELISTED
LHC Group LLC
LHCG
| $308K | ﹤0.01% |
1,885
| – | – |
|
4130
PUT
GrowGeneration
GRWG
$88.3M
| $307K | ﹤0.01% |
87,600
-50,000
| -36% | -$231K |
|
4131
Tyra Biosciences
TYRA
$1.85B
| $307K | ﹤0.01% |
34,886
-21,168
| -38% | -$194K |
|
4132
Enterprise Financial Services Corp
EFSC
$2.43B
| $305K | ﹤0.01% |
+6,920
| New | +$315K |
|
4133
PUT
Haleon
HLN
$45.2B
| $305K | ﹤0.01% |
+50,000
| New | +$324K |
|
|
CCXI
4134
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
| $305K | ﹤0.01% |
+5,900
| New | +$244K |
|
|
MN
4135
DELISTED
MANNING & NAPIER, INC.
MN
| $305K | ﹤0.01% |
+24,827
| New | +$313K |
|
4136
Stellantis
STLA
$16.7B
| $304K | ﹤0.01% |
25,692
| – | – |
|
|
ROIVW
4137
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
| $304K | ﹤0.01% |
779,218
+536,300
| +221% | +$285K |
|
4138
DexCom
DXCM
$29.2B
| $303K | ﹤0.01% |
3,761
+103
| +3% | +$8.72K |
|
4139
Primis Financial Corp
FRST
$394M
| $303K | ﹤0.01% |
24,966
+6,457
| +35% | +$85.4K |
|
4140
Antero Midstream
AM
$10.3B
| $302K | ﹤0.01% |
32,899
-22,369
| -40% | -$220K |
|
|
EVOP
4141
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $302K | ﹤0.01% |
9,082
-47,092
| -84% | -$1.45M |
|
4142
Freshpet
FRPT
$3.05B
| $301K | ﹤0.01% |
+6,000
| New | +$283K |
|
4143
RE/MAX Holdings
RMAX
$207M
| $301K | ﹤0.01% |
+15,908
| New | +$378K |
|
4144
Upstart Holdings
UPST
$2.65B
| $301K | ﹤0.01% |
14,501
+893
| +7% | +$24K |
|
|
BRSL
4145
Brightstar Lottery PLC
BRSL
$1.94B
| $300K | ﹤0.01% |
18,984
| – | – |
|
4146
Archer Aviation
ACHR
$3.7B
| $299K | ﹤0.01% |
114,749
-286,881
| -71% | -$1.01M |
|
4147
CALL
Oscar Health
OSCR
$9.37B
| $299K | ﹤0.01% |
60,000
| – | – |
|
|
DOOR
4148
CALL
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $299K | ﹤0.01% |
4,200
+600
| +17% | +$49.8K |
|
4149
Annexon
ANNX
$826M
| $297K | ﹤0.01% |
48,025
+9,699
| +25% | +$52.4K |
|
4150
Financial Institutions
FISI
$821M
| $296K | ﹤0.01% |
+12,310
| New | +$320K |
|
Similar funds
D.E. Shaw & Co's Q3 2022 Portfolio in Review
As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.
- D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
- D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
- D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.